| Virtual screening with solvation and ligand-induced complementarity V Schnecke, LA Kuhn Virtual Screening: An Alternative or Complement to High Throughput Screening …, 2002 | 264 | 2002 |
| Screening a peptidyl database for potential ligands to proteins with side‐chain flexibility V Schnecke, CA Swanson, ED Getzoff, JA Tainer, LA Kuhn Proteins: Structure, Function, and Bioinformatics 33 (1), 74-87, 1998 | 179 | 1998 |
| Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database CL Haase, S Lopes, AH Olsen, A Satylganova, V Schnecke, P McEwan International Journal of Obesity 45 (6), 1249-1258, 2021 | 143 | 2021 |
| Hybrid genetic algorithms for constrained placement problems V Schnecke, O Vornberger IEEE Transactions on Evolutionary Computation 1 (4), 266-277, 1997 | 135 | 1997 |
| Elevated plasma levels of MMP-12 are associated with atherosclerotic burden and symptomatic cardiovascular disease in subjects with type 2 diabetes I Goncalves, E Bengtsson, HM Colhoun, AC Shore, C Palombo, A Natali, ... Arteriosclerosis, thrombosis, and vascular biology 35 (7), 1723-1731, 2015 | 132 | 2015 |
| Computational chemistry-driven decision making in lead generation V Schnecke, J Boström Drug discovery today 11 (1-2), 43-50, 2006 | 104 | 2006 |
| Structure-based ligand design to overcome CYP inhibition in drug discovery projects G Brändén, T Sjögren, V Schnecke, Y Xue Drug discovery today 19 (7), 905-911, 2014 | 97 | 2014 |
| Work-load balancing in highly parallel depth-first search A Reinefeld, V Schnecke Proceedings of IEEE scalable high performance computing conference, 773-780, 1994 | 69 | 1994 |
| An adaptive parallel genetic algorithm for VLSI-layout optimization V Schnecke, O Vornberger International Conference on Parallel Problem Solving from Nature, 859-868, 1996 | 58 | 1996 |
| Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in … CL Haase, A Varbo, PN Laursen, V Schnecke, AH Balen Human Reproduction 38 (3), 471-481, 2023 | 57 | 2023 |
| Body mass index and risk of obesity‐related conditions in a cohort of 2.9 million people: evidence from a UK primary care database CL Haase, KT Eriksen, S Lopes, A Satylganova, V Schnecke, P McEwan Obesity Science & Practice, 2020 | 46 | 2020 |
| Database screening for HIV protease ligands: the influence of binding-site conformation and representation on ligand selectivity. V Schnecke, LA Kuhn ISMB, 242-251, 1999 | 45 | 1999 |
| Genetic design of VLSI-layouts V Schnecke, O Vornberger First International Conference on Genetic Algorithms in Engineering Systems …, 1995 | 43 | 1995 |
| Impact of CKD progression on cardiovascular disease risk in a contemporary UK cohort of individuals with diabetes CS Cabrera, AS Lee, M Olsson, V Schnecke, K Westman, M Lind, ... Kidney international reports 5 (10), 1651-1660, 2020 | 39 | 2020 |
| Design of small molecule inhibitors of acetyl-CoA carboxylase 1 and 2 showing reduction of hepatic malonyl-CoA levels in vivo in obese Zucker rats C Bengtsson, S Blaho, DB Saitton, K Brickmann, J Broddefalk, ... Bioorganic & medicinal chemistry 19 (10), 3039-3053, 2011 | 37 | 2011 |
| AIDA^*-Asynchronous Parallel IDA^ A Reinefeld, V Schnecke Proceedings of the Biennial Conference-Canadian Society for Computational …, 1994 | 37 | 1994 |
| A randomized controlled trial of dapagliflozin plus once-weekly exenatide versus placebo in individuals with obesity and without diabetes: metabolic effects and markers … MJ Pereira, P Lundkvist, PG Kamble, J Lau, JG Martins, CD Sjöström, ... Diabetes Therapy 9, 1511-1532, 2018 | 31 | 2018 |
| Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes I Gonçalves, A Edsfeldt, HM Colhoun, AC Shore, C Palombo, A Natali, ... BMC cardiovascular disorders 16, 1-10, 2016 | 23 | 2016 |
| Hybrid genetic algorithms for solving constrained packing and placement problems V Schnecke Osnabrück, 1996 | 22 | 1996 |
| The discovery of a novel series of glucokinase activators based on a pyrazolopyrimidine scaffold P Bonn, DM Brink, J Fägerhag, U Jurva, GR Robb, V Schnecke, ... Bioorganic & medicinal chemistry letters 22 (24), 7302-7305, 2012 | 21 | 2012 |
Jonas BoströmTreeline Biosciences,US在 treeline.bio 的电子邮件经过验证
